Tag: biomedical
-
Trial to Test Drug Combination for Hospital Infections
A clinical trial scheduled for early 2017 plans to assess the activity of two drugs to treat antibiotic-resistant infections often found in health care facilities.
-
ALS Soy Peptide Trial Completes Enrollment
A clinical trial testing a peptide found in soy as a potential treatment for amyotrophic lateral sclerosis or ALS completed its enrollment of 50 participants.
-
3-D Printing Creates Heart-on-Chip with Sensors
Biomedical engineers at Harvard University developed a programmable and automated process for creating miniature organs on chips with integrated sensors using 3-D printing.
-
Biotech, Novartis Partner on Rare Metabolic Diseases
A biotechnology start-up enterprise using genome editing for drug discovery is collaborating with drug maker Novartis on rare metabolic disorders.
-
Virtual Reality Game in Development for Vision Disorder
An engineering lab at New Jersey Institute of Technology is creating a virtual reality therapy game to treat children with binocular vision dysfunction.
-
Mobile Multichannel Biomarker Detector Designed
An engineering lab designed a portable testing device connected to a smartphone that can analyze multiple specimen samples for a leading cancer biomarker.
-
Start-Up to Commercialize New Parkinson’s Treatment
Mavalon Therapeutics, a new company in the U.K., is being formed to bring a treatment to market that stops the progression of Parkinson’s disease.
-
Clinical Trial Network for Lupus Formed
A network of medical researchers is being assembled to conduct clinical trials to test new therapies for lupus and drugs approved for other disorders that may also treat the disease.
-
Commercial Genome Service Launches Based on Open Data
A start-up software company is offering genetic analysis services for research and precision medicine that comply with open standards and access Google’s genomic data sets.
-
Trial Testing Retina Cell Implants for Glaucoma
A new clinical trial is testing implants to treat glaucoma made of genetically engineered retina cells that release hormones promoting optic nerve growth.